Blood pressure categories and cardiovascular risk factors in Japan: The Jichi Medical School (JMS) cohort study

Hypertension Research

Volumn 30, Issue 7, 2007, Pages 643-649

  Ishikawa, Shizukiyo ^a   Shibano, Yoshihiro ^b   Asai, Yasuhiro ^a   Kario, Kazuomi ^a   Kayaba, Kazunori ^c   Kajii, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Iwaizumi Hospital   (Japan)

^c SAITAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Blood pressure category; Hypertension; Japanese; Population; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7C; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RURAL AREA; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34548034484     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.643     Document Type: Article

References (37)

1. Ohmori S, Kiyohara Y, Kato I, et al: Hyperinsulinaemia and blood pressure in a general Japanese population: the Hisayama Study, J Hypertens 1994; 12: 1191-1197.
2. Imai Y, Tsuji I, Nagai K, et al: Ambulatory blood pressure monitoring in evaluating the prevalence of hypertension in adults in Ohasama, a rural Japanese community. Hypertens Res 1996; 19: 207-212.
3. Imazu M, Sumida K, Yamabe T, et al: A comparison of the prevalence and risk factors of high blood pressure among Japanese living in Japan, Hawaii, and Los Angeles. Public Health Rep 1996; 2: 59-61.
4. Burt V, Whelton P, Roccella E, et al: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
5. Hansson L, Zanchetti A: The Hypertension Optimal Treatment (HOT) Study - patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press 1994; 3: 322-327.
6. Kaplan RC, Psaty BM, Heckbert SR, Smith NL, Lemaitre RN: Blood pressure level and incidence of myocardial infarction among patients treated for hypertension. Am J Public Health 1999; 89: 1414-1417.
7. Klungel O, Kaplan R, Heckbert S, et al: Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 2000; 31: 420-424.
8. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995; 346: 1647-1653.
9. Ueda K, Omae T, Hasuo Y, et al: Prevalence and long-term prognosis of mild hypertensives and hypertensives in a Japanese community, Hisayama. J Hypertens 1988; 6: 981-989.
10. Kannel W: Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571-1576.
11. Bulpitt C, Palmer A, Fletcher A, et al: Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994; 90: 225-233.
12. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J: Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998; 32: 998-1002.
13. Shapo L, Pomerleau J, McKee M: Epidemiology of hypertension and associated cardiovascular risk factors in a country in transition: a population based survey in Tirana City, Albania. J Epidemiol Community Health 2003; 57: 734-739.
14. Cifkova R, Skodova Z, Lanska V, et al: Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens 2004; 18: 571-579.
15. Wang Z, Wu Y, Zhao L, Li Y, Yang J, Zhou B: Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertens Res 2004; 27: 703-709.
16. Wolf-Maier K, Cooper RS, Kramer H, et al: Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10-17.
17. Nago N, Kayaba K, Hiraoka J, et al: Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study. Am J Epidemiol 1995; 141: 815-821.
18. Ishikawa S, Gotoh T, Nago N, Kayaba K: The Jichi Medical School (JMS) Cohort Study: design, baseline data and standardized mortality ratios. J Epidemiol 2002; 12: 408-417.
19. Kannel W, Sorlie P: Some health benefits of physical activity. The Framingham Study. Arch Intern Med 1979; 139: 857-861.
20. Davis C, Rifkind B, Brenner H, Gordon D: A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the Lipid Research Clinics Mortality Follow-up Study. JAMA 1990; 264: 3044-3046.
21. Perry HJ, Miller J: Difficulties in diagnosing hypertension: implication and alternatives. J Hypertens 1992; 10: 887-896.
22. Eastern Stroke and Coronary Heart Disease Collaborative Research Group: Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998; 352: 1801-1807.
23. Du X, Cruickshank K, McNamee R, et al: Case-control study of stroke and the quality of hypertension control in north west England. BMJ 1997; 314: 272-276.
24. Makino Y, Kawano Y, Minami J, Yamaguchi T, Takishita S: Risk of stroke in relation to level of blood pressure and other risk factors in treated hypertensive patients. Stroke 2000; 31: 48-52.
25. MacMahon S, Peto R, Cutler J, et al: Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
26. Gueyffier F, Boutitie F, Boissel J, et al: Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997; 126: 761-767.
27. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
28. Tomiyama H, Arai T, Koji Y, et al: The age-related increase in arterial stiffness is augmented in phases according to the severity of hypertension. Hypertens Res 2004; 27: 465-470.
29. Steinberg D, Pearson TA, Kuller LH: Alcohol and atherosclerosis. Ann Intern Med 1991; 114: 967-976.
30. Kiechl S, Willeit J, Poewe W, et al: Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ 1996; 313: 1040-1044.
31. Yamamoto A, Temba H, Horibe H, et al: Life style and cardiovascular risk factors in the Japanese population-from an epidemiological survey on serum lipid levels in Japan 1990 part 2: association of lipid parameters with hypertension. J Atheroscler Thromb 2003; 10: 176-185.
32. Ohkubo T, Obara T, Funahashi J, et al: Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2004; 27: 755-763.
33. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M: Hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in apparently healthy Japanese individuals. Hypertens Res 2005; 28: 27-34.
34. Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men - the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203-208.
35. Tsubakimoto A, Saito I, Mannami T, et al: Impact of metabolic syndrome on brachial-ankle pulse wave velocity in Japanese. Hypertens Res 2006; 29: 29-37.
36. Sasanabe R, Banno K, Otake K, et al: Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res 2006; 29: 315-322.
37. Ishikawa S, Kayaba K, Gotoh T, Nakamura Y, Kajii E: Metabolic syndrome and C-reactive protein in the general population. Circ J 2007; 71: 26-31.